Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Top 3 Health Care Stocks That Are Set To Fly In Q2 - Genprex (NASDAQ ...
Genprex Announces Groundbreaking Data From Non-Human Primate Study ...
Genprex Appoints Jan Stevens, RN, as Vice President of Clinical ...
Genprex inks sponsored research agreement with the University of ...
Genprex to Present and Participate at Upcoming September Investor and ...
Genprex is Defining a New Immunogene Therapy that Could Change the ...
Genprex unveils groundbreaking data from primate study on its novel ...
Genprex to Participate in March Investor and Industry Conferences – Genprex
Genprex Signs Sponsored Research Agreement with the University of ...
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination ...
Genprex to Receive Inaugural “License of the Year” Award from ...
Genprex Announces Centralized Institutional Review Board Approval for ...
Genprex Oncoprex screenshot
Genprex to Participate in Panel at Life Sciences Summit on November 17 ...
Genprex Collaborators Present Positive Preclinical Data on Reqorsa ...
Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa ...
Genprex (GNPX) Stock Soars on Lung Cancer Gene Therapy Data - Parameter
Genprex Announces Sponsored Research Agreement with The University of ...
Genprex shares fall 22.14% premarket amid unclear catalyst despite ...
Genprex Collaborators to Present Positive Preclinical Data on the Use ...
Genprex Provides Update on Development of its Oncoprex Immunogene ...
Genprex Announces the Passing of its Co-Founder and Chief Executive ...
Genprex Receives U.S. FDA Fast Track Designation for REQORSA ...
Genprex Strengthens Diabetes Gene Therapy Program with License of ...
Genprex Granted Patent in Singapore for Gene Therapy to Treat Cancers ...
Genprex Collaborators Report Positive Preclinical Data With NPRL2 Gene ...
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies ...
Genprex Unveils New Video Featuring Chief Medical Officer Discussing ...
Genprex to Showcase Gene Therapies for Cancer and Diabetes at BIO 2025 ...
Genprex Announces European Patent Office’s Intent to Grant a Patent for ...
Genprex Collaborators to Present Positive Preclinical Data on Reqorsa ...
Genprex to Present Trial Design of Acclaim-3 Clinical Trial Evaluating ...
Genprex Appoints Suzanne Thornton-Jones as Senior Vice President ...
Genprex Receives Patent Allowances for Reqorsa Combination Therapies ...
Genprex to Host a Virtual Key Opinion Leader Event on “Bringing Gene ...
Independent Researchers Find That TUSC2, the Gene Delivered by Genprex ...
Genprex Collaborators Report Positive Preclinical Data on the Use of ...
Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare ...
The results are in, Genprex (NASDAQ: GNPX) announces positive ...
Genprex (GNPX) Surges 26.8% on Preclinical Breakthroughs and ...
Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell ...
Genprex Announces Registered Direct Offering of up to $8.2 Million ...
News – Genprex
Genprex Announces Formation of Clinical Advisory Board – Genprex
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung ...
Genprex Granted FDA Orphan Drug Designation (ODD) for REQORSA ...
Genprex (GNPX) up more than 300% since Sep 29
Genprex Signs License Deal With University Of Michigan For Lung Cancer ...
Genprex is Pioneering the Use of Non-Viral Vectors in Gene Therapy ...
Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® Delivery ...
Genprex Collaborators Report Positive Preclinical Data for REQORSA ...
Genprex to Participate at BIO Europe Spring 2025 – Genprex
Genprex Signs Exclusive License to Additional Gene Therapy Technologies ...
Genprex Announces $7.5 Million Registered Direct Offering Priced At-the ...
Genprex Granted FDA Orphan Drug Designation for REQORSA Immunogene ...
Genprex Enters $12.5M Stock Purchase Agreement - TipRanks.com
Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for ...
Genprex Stock Quote GNPX - Stock Price, News, Charts, Message Board, Trades
Genprex Announces Groundbreaking Data from Non-Human Primate Study ...
Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene ...
Genprex Inc.: Navigating the Financial Waters Amidst Market Volatility
Genprex (GNPX) Price Target Increased by 45.45% to 8.16 | Nasdaq
About Us – Genprex
Genprex, Inc. on LinkedIn: Genprex (NASDAQ: GNPX): focused on ...
Genprex (GNPX) Surges 21% on Intraday Rally – What’s Fueling the ...
Genprex, Inc. on LinkedIn: Genprex had so much fun participating in the ...
Genprex Announces U.S. Patent for REQORSA™ Immunogene Therapy in ...
Genprex to Participate in a Monthly CEO Roadshow Webinar Series ...
Genprex and University of Pittsburgh sign new agreement to study GPX ...
Genprex (GNPX.O) Surges 20% — What’s Driving This Unusual Move?
Genprex Stock Sees Surprising Climb: Are New Trials Boosting Investor ...
Genprex advances to highest dose in Phase I trial of Reqorsa
Genprex boosts its diabetes gene therapy program with the license of ...
Genprex receives orphan drug designation from the FDA for quaratusugene ...
Genprex Plummets 21% on $10M Capital Raise Amid Preclinical Hype
Genprex Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD ...
Genprex and University of Pittsburgh Sign Exclusive License Agreement ...
Genprex expanding trial research and portfolio for cancer and diabetic ...
Genprex Wins FDA Fast Track Status for its Oncoprex Therapy in ...
Genprex cancer gene therapy paired with AZ, Merck lung cancer drugs ...
Austin-based Genprex shares promising gene therapy developments for ...
How Genprex Differs From “Traditional” Gene Therapy Approaches – Genprex
Data from Genprex’s Acclaim-1 Phase 1 Gene Therapy Clinical Trial ...
Genprex, Inc. Prices $17,500,000 Common Stock Offering Priced At-The ...
Genprex’s Novel Immunogene Therapy in Lung Cancer Highlighted in Key ...
Genprex, Inc. Announces Closing of $8 Million At-The-Market Common ...
Genprex’s Non-Viral Delivery System Once Again Ahead of Recent Industry ...
Gene Therapy Stock Genprex, Inc. (NASDAQ: GNPX) Makes Nasdaq Top ...
Genprex, Inc. on LinkedIn: #sclc
Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in ...
Genprex, Inc. on LinkedIn: #oncology #lungcancer #genetherapy
Genprex, Inc. on LinkedIn: #bioeuropespring #cancer #diabetes
Genprex, Inc. on LinkedIn: Genprex's Executive Vice President, General ...
Genprex, Inc. Announces $12 Million Registered Direct Offering Priced ...
Genprex’s Reqorsa Gene Therapy - Mesothelioma Gene Treatment
Genprex’s Gene Therapy Shows Promise in Overcoming Lung Cancer ...
Genprex, Inc. (NASD:GNPX) Seasonal Chart | Equity Clock
Genprex, Inc. on LinkedIn: #genetherapy #diabetes #attd2023
Genprex's Gene Therapy: Potential Breakthrough For Diabetes, Lung ...
Genprex, Inc. | LinkedIn
March 23 2023
IBN Announces Latest Episode of The Bell2Bell Podcast featuring CEO ...
Genprex, Inc. on LinkedIn: #cancerimmunotherapymonth
Genprex, Inc. on LinkedIn: #bioceo24 #biotech
Genprex, Inc. on LinkedIn: #nationalcancersurvivorsday
Genprex, Inc. on LinkedIn: #bioeurope2022 #cancer #diabetes
Genprex, Inc. on LinkedIn: #oncology #genetherapy
Genprex, Inc. on LinkedIn: #oncology #kras
Genprex, Inc. on LinkedIn: #attd2023 #diabetes
Genprex, Inc. on LinkedIn: #bioeurope #genetherapy #cancer #diabetes
FDA grants Fast Track status to Genprex’s drug for NSCLC treatment
